Work

Supplementary Figure 1 from Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic Cancers

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Figure 1. TPO171 transgenic thyroid tissues are stained with CD3-specific and cleft caspase 3 (ClC3)-specific antibodies following treatment with active LMB100 itox (left set of images) vs. LMB100 inactive mutant variant (right set of images).

DOI: 10.1158/1535-7163.22521738.v1

Authors: Brendan Hagerty, T. Norene O'Sullivan, Xianyu Zhang, N. Keith Collins, Wendi Custer Lawrence, Laura L. Bassel, Nathan Pate, Jian Xu, Theresa M. Guerin, Serguei Kozlov, Christine Alewine

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362624935

Cites:

Cited by:

Related to: 10